[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Teichmann et al., 2010 - Google Patents

Modulation of SHP‐1 phosphatase activity by monovalent and bivalent SH2 phosphopeptide ligands

Teichmann et al., 2010

Document ID
6498511867417394800
Author
Teichmann K
Kühl T
Könnig I
Wieligmann K
Zacharias M
Imhof D
Publication year
Publication venue
Biopolymers: Original Research on Biomolecules

External Links

Snippet

A sequence derived from the epithelial receptor tyrosine kinase Ros (pY2267) represents a high‐affinity binding partner for protein tyrosine phosphatase SHP‐1 and was recently used as lead structure to analyze the recognition requirements for the enzyme's N‐SH2 domain …
Continue reading at onlinelibrary.wiley.com (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies

Similar Documents

Publication Publication Date Title
Liu et al. Membrane permeable cyclic peptidyl inhibitors against human Peptidylprolyl Isomerase Pin1
Bolin et al. Peptide and peptide mimetic inhibitors of antigen presentation by HLA-DR class II MHC molecules. Design, structure− activity relationships, and x-ray crystal structures
Zhang et al. Recent progress and clinical development of inhibitors that block MDM4/p53 protein–protein interactions
Rai Peptide and protein mimetics by retro and retroinverso analogs
Wang et al. Ezrin-anchored protein kinase A coordinates phosphorylation-dependent disassembly of a NHERF1 ternary complex to regulate hormone-sensitive phosphate transport
CA2638866C (en) Peptide based inhibition of capcna protein-protein interactions in cancer
Lerch et al. Structural and biophysical coupling of heparin and activin binding to follistatin isoform functions
Mungalpara et al. Rational design of conformationally constrained cyclopentapeptide antagonists for CXC chemokine receptor 4 (CXCR4)
Puhl et al. Discovery and characterization of peptide inhibitors for calcium and integrin binding protein 1
Nubbemeyer et al. Strategies towards targeting Gαi/s proteins: Scanning of protein‐protein interaction sites to overcome inaccessibility
Kamikubo et al. Disulfide bonding arrangements in active forms of the somatomedin B domain of human vitronectin
Fedorczyk et al. Conformational latitude–activity relationship of KPPR tetrapeptide analogues toward their ability to inhibit binding of vascular endothelial growth factor 165 to neuropilin‐1
CN1886148B (en) Selective inhibition of NF-kB activation by peptides designed to disrupt NEMO oligomerization
Tran et al. Insights into human Lck SH3 domain binding specificity: different binding modes of artificial and native ligands
Autenrieth et al. Defining A‐kinase anchoring protein (AKAP) specificity for the protein kinase A subunit RI (PKA‐RI)
Muratspahic et al. Development of a selective peptide κ-opioid receptor antagonist by late-stage functionalization with cysteine staples
Iaccarino et al. Structure-based design of small bicyclic peptide inhibitors of Cripto-1 activity
Torheim et al. Design of proteolytically stable RI-anchoring disruptor peptidomimetics for in vivo studies of anchored type I protein kinase A-mediated signalling
Gunzburg et al. Design and testing of bicyclic inhibitors of Grb7—Are two cycles better than one?
Teichmann et al. Modulation of SHP‐1 phosphatase activity by monovalent and bivalent SH2 phosphopeptide ligands
Szewczuk et al. Immunosuppressory activity of ubiquitin fragments containing retro‐RGD sequence
Mann et al. Enhancement of muramyl dipeptide‐dependent NOD2 activity by a self‐derived peptide
Abayev et al. An extended CCR 5 ECL 2 peptide forms a helix that binds HIV‐1 gp120 through non‐specific hydrophobic interactions
Imhof et al. Design and biological evaluation of linear and cyclic phosphopeptide ligands of the N-terminal SH2 domain of protein tyrosine phosphatase SHP-1
Hampel et al. Phosphopeptide Ligands of the SHP‐1 N‐SH2 Domain: Effects on Binding and Stimulation of Phosphatase Activity